Skip to content
healthcare.dev
Get a free key

Cetirizine Hydrochloride Hives Relief

NDC 65162-145, Cetirizine, tablet, from Amneal Pharmaceuticals LLC.

Product NDC
65162-145
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA078780
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65162-145 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE5 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
65162-145-03651620145031 BOTTLE in 1 CARTON (65162-145-03) / 30 TABLET in 1 BOTTLE
65162-145-5065162014550500 TABLET in 1 BOTTLE (65162-145-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 65162-145 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65162-145 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65162-145. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.